Lilyana Amezcua

Oct 31, 2023 | journals.sagepub.com | Daniel Ontaneda |Lilyana Amezcua

Get full access to this articleView all access and purchase options for this article. References1. Howard J, Trevick S, Younger DS. Epidemiology of multiple sclerosis. Neurol Clin 2016; 34: 919–939. 2. Solomon AJ, Marrie RA, Viswanathan S, et al. Global barriers to the diagnosis of multiple sclerosis: Data from the multiple sclerosis international federation atlas of MS, third edition. Neurology 2023; 106: e624–e635. 3. Hittle M, Culpepper WJ, Langer-Gould A, et al.

Oct 31, 2023 | journals.sagepub.com | Daniel Ontaneda |Lilyana Amezcua

Multiple sclerosis (MS) has traditionally been viewed as predominantly affecting White people from North America or Europe.1 Indeed, a significant proportion of research involving people with MS has been based in Europe or North America. As a result, the epidemiology of MS is heavily influenced by how MS presents in White populations from these regions. Inaccurate inferences have been made that race is a decisive variable in who gets MS.

Oct 31, 2023 | journals.sagepub.com | Daniel Ontaneda |Lilyana Amezcua

Get full access to this articleView all access and purchase options for this article. References1. Howard J, Trevick S, Younger DS. Epidemiology of multiple sclerosis. Neurol Clin 2016; 34: 919–939. 2. Solomon AJ, Marrie RA, Viswanathan S, et al. Global barriers to the diagnosis of multiple sclerosis: Data from the multiple sclerosis international federation atlas of MS, third edition. Neurology 2023; 106: e624–e635. 3. Hittle M, Culpepper WJ, Langer-Gould A, et al.